CSL (Germany) Today
| CSJ Stock | EUR 103.90 1.94 1.83% |
PerformanceMild
| Odds Of DistressLow
|
CSL is trading at 103.90 as of the 3rd of February 2026. This is a 1.83 percent decrease since the beginning of the trading day. The stock's lowest day price was 103.9. CSL has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. The performance scores are derived for the period starting the 5th of November 2025 and ending today, the 3rd of February 2026. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia. The company has 485.15 M outstanding shares. More on CSL Limited
CSL Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. CSL's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding CSL or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, CSL's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to CSL's managers, analysts, and investors.
Environment Score | Governance Score | Social Score |
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
| Excise Tax Activities | Animal Testing | ||||
CSL's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to CSL's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
CSL utilizes debt financing to potentially enhance returns on invested capital. The relationship between total debt and total assets provides valuable insight into CSL's leverage profile, showing how much of CSL's resources are funded through borrowing.
| |||||
CSL Limited (CSJ) is traded on Frankfurt Exchange in Germany and employs 29,904 people. CSL is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 51.01 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CSL's market, we take the total number of its shares issued and multiply it by CSL's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. CSL Limited classifies itself under Biotechnology sector and is part of Health Care industry. The entity has 485.15 M outstanding shares.
CSL Limited has accumulated about 668.7 M in cash with 2.63 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.48.
Check CSL Probability Of Bankruptcy
Ownership AllocationCSL holds a total of 485.15 Million outstanding shares. 30% of CSL Limited outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Therefore, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check CSL Ownership Details
CSL Historical Income Statement
CSL Stock Against Markets
CSL Stock Analysis Notes
About 36.0% of the company shares are held by institutions such as insurance companies. The book value of CSL was currently reported as 33.7. The company recorded earning per share (EPS) of 5.15. CSL Limited last dividend was issued on the 9th of September 2025. The entity had 3:1 split on the 18th of October 2007. CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia. CSL LTD operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. For more info on CSL Limited please contact Paul BA at 61 3 9389 1911 or go to https://www.csl.com.CSL Quarterly Total Revenue |
|
CSL Limited Investment Alerts
| CSL Limited has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Latest headline from news.google.com: CSL share price rises as Vanguard lifts stake to 6 percent ahead of Feb. 11 results - TechStock |
CSL Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 51.01 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CSL's market, we take the total number of its shares issued and multiply it by CSL's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.CSL Profitablity
CSL's profitability indicators refer to fundamental financial ratios that showcase CSL's ability to generate income relative to its revenue or operating costs. If, let's say, CSL is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, CSL's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of CSL's profitability requires more research than a typical breakdown of CSL's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.19 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.19 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.19. Management Efficiency
CSL Limited has return on total asset (ROA) of 0.0663 % which means that it generated a profit of $0.0663 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1537 %, meaning that it generated $0.1537 on every $100 dollars invested by stockholders. CSL's management efficiency ratios could be used to measure how well CSL manages its routine affairs as well as how well it operates its assets and liabilities. At this time, CSL's Other Current Assets are most likely to increase significantly in the upcoming years.Leadership effectiveness at CSL Limited is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Technical Drivers
As of the 3rd of February, CSL shows the Risk Adjusted Performance of (0.04), coefficient of variation of (1,470), and Mean Deviation of 1.46. CSL Limited technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm CSL Limited maximum drawdown, and the relationship between the information ratio and potential upside to decide if CSL Limited is priced some-what accurately, providing market reflects its regular price of 103.9 per share.CSL Limited Price Movement Analysis
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. CSL Limited Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe CSL price patterns.
CSL Predictive Daily Indicators
CSL intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of CSL stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 4.46 | |||
| Daily Balance Of Power | (1.14) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 104.75 | |||
| Day Typical Price | 104.47 | |||
| Market Facilitation Index | 0.0061 | |||
| Price Action Indicator | (1.82) | |||
| Period Momentum Indicator | (1.94) | |||
| Relative Strength Index | 55.95 |
CSL Forecast Models
CSL's time-series forecasting models are one of many CSL's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary CSL's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Be your own money manager
Our tools can tell you how much better you can do entering a position in CSL without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Optimization Now
Portfolio OptimizationCompute new portfolio that will generate highest expected return given your specified tolerance for risk |
| All Next | Launch Module |
CSL Corporate Management
Elected by the shareholders, the CSL's board of directors comprises two types of representatives: CSL inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CSL. The board's role is to monitor CSL's management team and ensure that shareholders' interests are well served. CSL's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CSL's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Paul McKenzie | Chief Officer | Profile | |
| Chris Cooper | Head Relations | Profile | |
| Andy Schmeltz | Chief Officer | Profile | |
| BS BS | Exec Counsel | Profile | |
| Paul BA | CEO MD | Profile | |
| Ken Lim | Chief Officer | Profile | |
| BCom BComm | Chief Officer | Profile |
Other Information on Investing in CSL Stock
CSL financial ratios help investors to determine whether CSL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CSL with respect to the benefits of owning CSL security.